<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR14">
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Galani</surname>
    <given-names>IE</given-names>
   </name>
   <name>
    <surname>Triantafyllia</surname>
    <given-names>V</given-names>
   </name>
   <name>
    <surname>Eleminiadou</surname>
    <given-names>EE</given-names>
   </name>
   <name>
    <surname>Koltsida</surname>
    <given-names>O</given-names>
   </name>
   <name>
    <surname>Stavropoulos</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Manioudaki</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Thanos</surname>
    <given-names>D</given-names>
   </name>
   <name>
    <surname>Doyle</surname>
    <given-names>SE</given-names>
   </name>
   <name>
    <surname>Kotenko</surname>
    <given-names>SV</given-names>
   </name>
   <name>
    <surname>Thanopoulou</surname>
    <given-names>K</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Interferon-lambda mediates non-redundant front-line antiviral protection against influenza virus infection without compromising host fitness</article-title>
  <source>Immunity</source>
  <year>2017</year>
  <volume>46</volume>
  <issue>875â€“890</issue>
  <fpage>e876</fpage>
 </element-citation>
</ref>
